Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Blackstone proposes $2.5bn investment in potential $4bn New World transaction
Blackstone proposes $2.5bn investment in potential $4bn New World transaction Blackstone has proposed injecting approximately $2.5bn into a special-purpose vehicle tied to New World Development as part of a broader $4bn transaction under discussion, according to a...
Searchlight-backed Roots explores sale as shares trade near $2.35
Searchlight-backed Roots explores sale as shares trade near $2.35 Searchlight Capital Partners-backed Roots Corp. has launched a strategic review that could lead to a sale of the Canadian clothing brand, according to Bloomberg sources. The company has appointed...
Kushner’s Thrive Capital and Andreessen lead $4bn Anduril round at $60bn valuation
Kushner's Thrive Capital and Andreessen lead $4bn Anduril round at $60bn valuation Thrive Capital and Andreessen Horowitz are co-leading a $4bn fundraising round for Anduril Industries, valuing the defence technology group at approximately $60bn, according to...